Found: 262
Select item for more details and to access through your institution.
Regional Myocardial Contractile Response to the Beta-Adrenergic Stimulant Prenalterol in the Conscious Dog following Myocardial Infarction.
- Published in:
- Pharmacology, 1984, v. 28, n. 1, p. 51, doi. 10.1159/000137943
- By:
- Publication type:
- Article
Moving Forward by Looking Backwards: The Role of Combination Therapy With a Mineralocorticoid Receptor Antagonist and a Thiazide Diuretic in Patients With Hypertension.
- Published in:
- American Journal of Hypertension, 2024, v. 37, n. 4, p. 261, doi. 10.1093/ajh/hpae003
- By:
- Publication type:
- Article
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence.
- Published in:
- American Journal of Hypertension, 2024, v. 37, n. 1, p. 1, doi. 10.1093/ajh/hpad073
- By:
- Publication type:
- Article
Efficacy and Safety of Ocedurenone: Subgroup Analysis of the BLOCK-CKD Study.
- Published in:
- American Journal of Hypertension, 2023, v. 36, n. 11, p. 612, doi. 10.1093/ajh/hpad066
- By:
- Publication type:
- Article
Mineralocorticoid Receptor Antagonists in ST-Segment Elevation Myocardial Infarction.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 2, p. 372, doi. 10.1093/ndt/gfac157
- By:
- Publication type:
- Article
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 7, p. 1261, doi. 10.1093/ndt/gfab336
- By:
- Publication type:
- Article
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 6, p. 1014, doi. 10.1093/ndt/gfaa294
- By:
- Publication type:
- Article
Prognostic relevance of magnesium alterations in patients with amyocardial infarction and left ventricular dysfunction: insights from the EPHESUS trial.
- Published in:
- European Heart Journal: Acute Cardiovascular Care, 2022, v. 11, n. 2, p. 148, doi. 10.1093/ehjacc/zuab111
- By:
- Publication type:
- Article
Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-riskmyocardial infarction database.
- Published in:
- European Heart Journal: Acute Cardiovascular Care, 2021, v. 10, n. 2, p. 127, doi. 10.1093/ehjacc/zuaa012
- By:
- Publication type:
- Article
Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction database.
- Published in:
- European Heart Journal: Acute Cardiovascular Care, 2021, p. 127, doi. 10.1093/ehjacc/zuaa012
- By:
- Publication type:
- Article
Prostaglandins and prostaglandin inhibitors in ischemic heart disease.
- Published in:
- 1983
- By:
- Publication type:
- journal article
The renin‐angiotensin‐aldosterone system and its suppression.
- Published in:
- Journal of Veterinary Internal Medicine, 2019, v. 33, n. 2, p. 363, doi. 10.1111/jvim.15454
- By:
- Publication type:
- Article
Renal outcomes in hypertensive Black patients at high cardiovascular risk.
- Published in:
- Kidney International, 2012, v. 81, n. 6, p. 568, doi. 10.1038/ki.2011.417
- By:
- Publication type:
- Article
Corrigendum: Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity.
- Published in:
- Nature Medicine, 2007, v. 13, n. 2, p. 189, doi. 10.1038/nm1545
- By:
- Publication type:
- Article
Scintigraphic Demonstration of Ventriculo Atrial Conduction in the Ventricular Pacemaker Syndrome.
- Published in:
- Journal of Nuclear Medicine, 1982, v. 23, n. 9, p. 795
- By:
- Publication type:
- Article
Thallium-201 Myocardial Scintigraphy: A Critical Comparison of Seven-Pinhole Tomography and Conventional Planar Imaging.
- Published in:
- Journal of Nuclear Medicine, 1981, v. 22, n. 6, p. 493
- By:
- Publication type:
- Article
PRINCIPLES OF NONINVASIVE CARDIAC IMAGING-ECHOCARDIOGRAPHY AND NUCLEAR CARDIOLOGY.
- Published in:
- Journal of Nuclear Medicine, 1981, v. 22, n. 4, p. 398
- By:
- Publication type:
- Article
Myocardial Imaging in Man with I-123 Meta-Iodobenzylguanidine.
- Published in:
- Journal of Nuclear Medicine, 1981, v. 22, n. 2, p. 129
- By:
- Publication type:
- Article
The Importance of Adequate Exercise in the Detection of Coronary Heart Disease by Radionuclide Ventriculography.
- Published in:
- Journal of Nuclear Medicine, 1980, v. 21, n. 12, p. 1125
- By:
- Publication type:
- Article
Cardiac Function in Patients with Prior Myocarditis.
- Published in:
- Journal of Nuclear Medicine, 1980, v. 21, n. 7, p. 689
- By:
- Publication type:
- Article
Segmental Wall-Motion Analysis in the Right Anterior Oblique Projection: Comparison of Exercise Equilibrium Radionuclide Ventriculography and Exercise Contrast Ventriculography.
- Published in:
- Journal of Nuclear Medicine, 1980, v. 21, n. 7, p. 617
- By:
- Publication type:
- Article
Clinical Comparison of Cardiac Blood Pool Visualization with Technetium-99m Red Blood Cells Labeled in Vivo and with Technetium-99m Human Serum Albumin.
- Published in:
- Journal of Nuclear Medicine, 1978, v. 19, n. 7, p. 796
- By:
- Publication type:
- Article
The Use of Videotape for Off-Line Viewing of Computer-Assisted Radionuclide Cardiology Studies.
- Published in:
- Journal of Nuclear Medicine, 1978, v. 19, n. 2, p. 210
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. C1, doi. 10.1111/dom.15423
- By:
- Publication type:
- Article
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 191, doi. 10.1111/dom.15305
- By:
- Publication type:
- Article
Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3410, doi. 10.1111/dom.15203
- By:
- Publication type:
- Article
Back Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. C4, doi. 10.1111/dom.15286
- By:
- Publication type:
- Article
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 10, p. 2989, doi. 10.1111/dom.15197
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1, doi. 10.1111/dom.15115
- By:
- Publication type:
- Article
Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1512, doi. 10.1111/dom.14999
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. C1, doi. 10.1111/dom.14995
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. C1, doi. 10.1111/dom.14960
- By:
- Publication type:
- Article
Effect of finerenone on the occurrence of vision‐threatening complications in patients with non‐proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 894, doi. 10.1111/dom.14915
- By:
- Publication type:
- Article
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon‐like peptide‐1 receptor agonist use.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 407, doi. 10.1111/dom.14883
- By:
- Publication type:
- Article
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 125, doi. 10.1111/dom.14558
- By:
- Publication type:
- Article
Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE‐HF trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1426, doi. 10.1111/dom.14352
- By:
- Publication type:
- Article
Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?
- Published in:
- European Heart Journal, 2024, v. 45, n. 10, p. 775, doi. 10.1093/eurheartj/ehae040
- By:
- Publication type:
- Article
Resistant hypertension: cardiorenal protection with mineralocorticoid receptor blockade.
- Published in:
- European Heart Journal, 2024, v. 45, n. 2, p. 136, doi. 10.1093/eurheartj/ehad299
- By:
- Publication type:
- Article
Carat, clarity, colour, and cut: grading the DIAMOND trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 37, p. 3702, doi. 10.1093/eurheartj/ehad469
- By:
- Publication type:
- Article
Prevention of cardiorenal damage: importance of albuminuria.
- Published in:
- European Heart Journal, 2023, v. 44, n. 13, p. 1112, doi. 10.1093/eurheartj/ehac683
- By:
- Publication type:
- Article
Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?
- Published in:
- European Heart Journal, 2022, v. 43, n. 45, p. 4754, doi. 10.1093/eurheartj/ehac417
- By:
- Publication type:
- Article
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2931, doi. 10.1093/eurheartj/ehac299
- By:
- Publication type:
- Article
Why are mineralocorticoid receptor antagonists the Cinderella in evidence-based treatment of myocardial infarction complicated with heart failure? Lessons from PARADISE-MI.
- Published in:
- European Heart Journal, 2022, v. 43, n. 14, p. 1428, doi. 10.1093/eurheartj/ehab717
- By:
- Publication type:
- Article
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.
- Published in:
- European Heart Journal, 2022, v. 43, n. 6, p. 474, doi. 10.1093/eurheartj/ehab777
- By:
- Publication type:
- Article
What can heart failure trialists learn from oncology trialists?
- Published in:
- European Heart Journal, 2021, v. 42, n. 24, p. 2373, doi. 10.1093/eurheartj/ehab236
- By:
- Publication type:
- Article
Detection of patients at risk of developing heart failure responsive to mineralocorticoid receptor antagonists (MRAs): new insights and opportunities.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Mark Nicholls speaks to Professor Bertram Pitt and his role as a pioneer in cardiology over the management of heart failure.
- Published in:
- European Heart Journal, 2020, v. 41, n. 17, p. 1615, doi. 10.1093/eurheartj/ehaa149
- By:
- Publication type:
- Article
Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.
- Published in:
- European Heart Journal, 2020, v. 41, n. 17, p. 1673, doi. 10.1093/eurheartj/ehaa132
- By:
- Publication type:
- Article